UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
__________________________

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of report (date of earliest event reported): November 13, 2015 (November 10, 2015)

(Exact name of registrant as specified in its charter)

Delaware
(State of incorporation)

001-36103
(Commission file number)
 
04-3536131
(IRS Employer Identification No.)
 
 
 
45 First Avenue
Waltham, Massachusetts
 
02451
(Address of principal executive offices)
 
(Zip Code)

(781) 622-1120
(Registrant's telephone number, including area code)
______________________________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 






Item 2.02. Results of Operations and Financial Condition.
On November 10, 2015, the registrant issued via press release earnings commentary and supplemental information for the fiscal quarter ended September 30, 2015. That press release is furnished as Exhibit 99.01 to this current Report on Form 8-K.
The information contained in this current Report on Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Item 7.01. Regulation FD Disclosure
On November 10, 2015, Tecogen Inc., (the "Company") presented the attached slides in an announced conference call. Those slides are being furnished as Exhibit 99.02 to this Current Report on Form 8-K.
The information in this Item 7.01 and Exhibits 99.02 to this Form 8-K shall not be deemed "filed" for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits
(d) Exhibits
The following exhibits relating to Item 2.02 and Item 7.01 shall be deemed to be furnished, and not filed:

Exhibit        Description
99.01        Press release, dated November 10, 2015, for the third quarter ended September 30, 2015.
99.02        Presentation dated November 10, 2015.

SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

TECOGEN INC.

By: /s/ David A. Garrison
David A. Garrison
Chief Financial Officer

Dated: November 13, 2015





Exhibit 99.01

Tecogen Announces Record Third Quarter Results & Rebranding of Emissions Technology
Ultera™ the New Force in Emissions Control

WALTHAM, Mass., November 10, 2015, Tecogen® Inc. (NASDAQ:TGEN), a manufacturer and installer of high efficiency, ultra-clean combined heat and power products including natural gas engine-driven cogeneration, air conditioning systems, and high-efficiency water heaters for industrial and commercial use, reported revenues of $4,676,042 for the quarter ended September 30, 2015 compared to $4,175,863 for the same period in 2014, an increase of 12%. Gross profit increased to $1,668,931 for the quarter ended September 30, 2015 compared to $1,089,471, an increase of 53%.
Speaking about the quarter, co-Chief Executive Officer Benjamin Locke noted, “Third quarter is our seasonally weakest quarter historically and this year followed that same pattern. Despite the challenges we delivered both year-on-year top line growth and margin improvement to produce our best third quarter to date, a solid result.”
In conjunction with the third quarter earnings numbers released today the Company is also announcing a re-branding of its breakthrough emissions control technology. Ultera™, Tecogen’s Ultra Low Emissions Reduction system, has reached a phase of development that merited its own unique stand-alone brand. The Ultera brand will better differentiate the Company’s valuable intellectual property as it is commercialized for new market applications, including automotive engines.
“We expect that over time Ultera will come to stand for the global preeminent force in emissions control technologies across categories,” said Robert Panora, Tecogen President, Chief Operating Officer, and one of the investors of the patented ultra-clean technology.
Major Highlights:
Financial
Gross margin in the third quarter 2015 increased to 35.7% compared to 26.1% in 2014, within prior 35-40% gross margin guidance range and an over 900 basis point improvement from the prior year period.
Keeping pace with growing revenues, sales backlog of equipment and installations grew to $11 million, in line with the Company’s goal of consistently delivering quarter-end product backlog greater than $10 million.
Gross profit for the third quarter of 2015 was $1,668,931 compared to $1,089,471, over 50% growth when compared to the same period in 2014.
Consolidated net loss, attributable to Tecogen, for the three months ended September 30, 2015 was $948,842 compared to $1,447,798 for the same period in 2014; an over 30% improvement in consolidated net loss and the lowest third quarter loss ever reported.
Net loss per share was $0.06 and $0.09 for the three months ended September 30, 2015 and 2014, respectively.



Exhibit 99.01

Sales & Operations
Product and total revenue grew to the highest ever reported for a third quarter period.
Notable sales during the quarter included 5 InVerde 100kW units for various New York City multi-unit residential buildings, reinforcing the strong suitability of Tecogen’s clean, efficient, inverter-based CHP system for that market.
Emissions program continues to gain traction with key wins in Southern California and a new branding initiative around Ultera.
Ilios continues pace to profitability.
Largest installation to date, 7 units, successfully commissioned in the quarter at landmark Florida laboratory.
Ilios products continued to gain traction in key territories with additional shipments to Hawaii and the opening up of the Atlanta market.
Continued execution on sales strategy with the addition of new sales representatives in both the Atlanta and Chicago markets.

Conference Call Scheduled for Today at 11:30 am ET
Tecogen will host a conference call today to discuss the second quarter results beginning at 11:30 am ET. To listen to the call dial (888) 349-0103 within the U.S., (855) 669-9657 from Canada, or (412) 902-0129 from other international locations.  Participants should ask to be joined to the Tecogen Inc. call. Please begin dialing at least 10 minutes before the scheduled starting time. The earnings press release will be available on the Company website at www.Tecogen.com in the "News and Events" section under "About Us."  The conference call will be recorded and available for playback one hour after the end of the call.  The earnings conference call will also be webcast live. To view the associated slides, register for and listen to the webcast, go to http://investors.tecogen.com/webcast. Following the call, the webcast will be archived for 30 days.

About Tecogen
Tecogen manufactures, installs, and maintains high efficiency, ultra-clean, combined heat and power products including natural gas engine-driven cogeneration, air conditioning systems, and high-efficiency water heaters for residential, commercial, recreational and industrial use. The company is known for cost efficient, environmentally friendly and reliable products for energy production that, through patented technology, nearly eliminate criteria pollutants and significantly reduce a customer’s carbon footprint.
In business for over 20 years, Tecogen has shipped more than 2,300 units, supported by an established network of engineering, sales, and service personnel across the United States. For more information, please visit www.tecogen.com

FORWARD-LOOKING STATEMENTS This press release contains forward-looking statements under the Private Securities Litigation Reform Act of 1995 that involve a number of risks and uncertainties. Important factors could cause actual results to differ materially from those indicated by such forward-looking statements, as disclosed on the Company's website and in Securities and Exchange Commission filings. The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not assume any obligation to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.

Tecogen Investor Relations & Media Contact Information:
Ariel F. Babcock, CFA
P: (781) 466-6413
E: Ariel.Babcock@tecogen.com

John N. Hatsopoulos
P: 781-622-1120
E: jhatsopoulos@tecogen.com



Exhibit 99.01

TECOGEN INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
As of September 30, 2015 and December 31, 2014 
(unaudited)
 
September 30, 2015
 
December 31, 2014
ASSETS
 
 
 
Current assets:
 

 
 

Cash and cash equivalents
$
3,970,011

 
$
1,186,033

Short-term investments, restricted
294,728

 
585,702

Accounts receivable, net
4,331,181

 
4,750,437

Unbilled revenue
1,801,055

 
696,912

Inventory, net
4,699,913

 
4,090,221

Due from related party
949,129

 
600,251

Deferred financing costs
50,201

 
50,201

Prepaid and other current assets
354,859

 
348,868

Total current assets
16,451,077

 
12,308,625

Property, plant and equipment, net
565,230

 
658,421

Intangible assets, net
1,046,316

 
1,011,300

Goodwill
40,870

 
40,870

Deferred financing costs, net of current portion
11,439

 
48,990

Other assets
58,425

 
53,325

TOTAL ASSETS
$
18,173,357

 
$
14,121,531

 
 
 
 
LIABILITIES AND STOCKHOLDERS’ EQUITY
 

 
 

Current liabilities:
 

 
 

Accounts payable
$
2,841,858

 
$
2,416,313

Accrued expenses
1,138,914

 
1,008,153

Deferred revenue
556,145

 
1,666,576

Total current liabilities
4,536,917

 
5,091,042

Long-term liabilities:
 

 
 

Deferred revenue, net of current portion
415,712

 
207,153

Senior convertible promissory note, related party
3,000,000

 
3,000,000

Total liabilities
7,952,629

 
8,298,195

Commitments and contingencies (Note 5)


 


 
 
 
 
Stockholders’ equity:
 

 
 

Tecogen Inc. stockholders’ equity:
 

 
 

Common stock, $0.001 par value; 100,000,000 shares authorized; 17,588,782 and 15,905,881 issued and outstanding at September 30, 2015 and December 31, 2014, respectively
17,589

 
15,906

Additional paid-in capital
31,455,719

 
25,088,213

Accumulated deficit
(20,884,168
)
 
(18,955,023
)
Total Tecogen Inc. stockholders’ equity
10,589,140

 
6,149,096

Noncontrolling interest
(368,412
)
 
(325,760
)
Total stockholders’ equity
10,220,728

 
5,823,336

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY
$
18,173,357

 
$
14,121,531

 



Exhibit 99.01

TECOGEN INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
For the three months ended September 30, 2015 and 2014
(unaudited)
 
Three months ended September 30,
 
Nine months ended September 30,
 
2015
 
2014
 
2015
 
2014
Revenues
 
 
 
 
 

 
 

Products
$
1,860,860

 
$
1,094,529

 
$
8,744,306

 
$
5,047,231

Services
2,815,182

 
3,081,334

 
8,419,001

 
7,884,246

Total revenues
4,676,042

 
4,175,863

 
17,163,307

 
12,931,477

Cost of sales
 
 
 
 
 

 
 

Products
1,262,480

 
1,052,199

 
6,040,533

 
4,043,783

Services
1,744,631

 
2,034,193

 
5,087,978

 
5,023,324

Total cost of sales
3,007,111

 
3,086,392

 
11,128,511

 
9,067,107

Gross profit
1,668,931

 
1,089,471

 
6,034,796

 
3,864,370

Operating expenses
 
 
 
 
 

 
 

General and administrative
1,864,529

 
1,738,429

 
5,942,161

 
5,387,098

Selling
521,924

 
476,601

 
1,339,982

 
1,303,329

Research and development
206,223

 
329,524

 
610,703

 
889,240

Total operating expenses
2,592,676

 
2,544,554

 
7,892,846

 
7,579,667

Loss from operations
(923,745
)
 
(1,455,083
)
 
(1,858,050
)
 
(3,715,297
)
Other income (expense)
 
 
 
 
 

 
 

Interest and other income
2,157

 
17,763

 
11,945

 
35,927

Interest expense
(68,216
)
 
(43,317
)
 
(128,626
)
 
(159,863
)
Total other expense, net
(66,059
)
 
(25,554
)
 
(116,681
)
 
(123,936
)
Consolidated net loss
(989,804
)
 
(1,480,637
)
 
(1,974,731
)
 
(3,839,233
)
Less: (Income) loss attributable to the noncontrolling interest
40,962

 
32,839

 
45,587

 
123,683

Net loss attributable to Tecogen Inc.
$
(948,842
)
 
$
(1,447,798
)
 
$
(1,929,144
)
 
$
(3,715,550
)
Net loss per share - basic and diluted
$
(0.06
)
 
$
(0.09
)
 
$
(0.12
)
 
$
(0.25
)
Weighted average shares outstanding - basic and diluted
17,153,999

 
15,447,726

 
16,575,879

 
15,160,041

 




Exhibit 99.01

TECOGEN INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
For the nine months ended September 30, 2015 and 2014
(unaudited)
 
September 30,
 
2015
 
2014
CASH FLOWS FROM OPERATING ACTIVITIES:
 
 
 
Consolidated net loss
$
(1,974,731
)
 
$
(3,839,233
)
Adjustments to reconcile net loss to net cash used in operating activities:
 
 
 
Depreciation and amortization
205,262

 
250,655

Change in provision for allowance on accounts receivable

 
18,000

Recovery for inventory reserve
(25,000
)
 

Stock-based compensation
90,971

 
120,972

Non-cash interest expense
37,550

 

Gain on sale of assets
(4,631
)
 

Changes in operating assets and liabilities
 
 
 
(Increase) decrease in:
 
 
 
Short term investments
290,974

 

Accounts receivable
419,256

 
(796,659
)
Unbilled revenue
(1,104,143
)
 
521,327

Inventory, net
(584,692
)
 
(1,563,642
)
Due from related party
(348,878
)
 
(125,069
)
Prepaid expenses and other current assets
(5,991
)
 
1,756

Other non-current assets
(5,100
)
 
19,100

Increase (decrease) in:
 
 
 
Accounts payable
425,545

 
747,810

Accrued expenses
130,761

 
(149,470
)
Deferred revenue
(901,872
)
 
1,315,434

Due to related party

 
(119,667
)
Interest payable, related party

 
(198,450
)
Net cash used in operating activities
(3,354,719
)
 
(3,797,136
)
CASH FLOWS FROM INVESTING ACTIVITIES:
 
 
 
Purchases of property and equipment
(48,827
)
 
(148,833
)
Proceeds from sale of assets
16,874

 

Disposal of property and equipment


 
7,569

Purchases of intangible assets
(110,502
)
 
(130,905
)
Purchases of short-term investments, restricted

 
(585,038
)
Net cash used in investing activities
(142,455
)
 
(857,207
)
CASH FLOWS FROM FINANCING ACTIVITIES:
 
 
 
Payments for debt issuance costs

 
(9,668
)
Proceeds (payments) on demand notes payable and line of credit to related party

 
(2,950,000
)
Proceeds from sale of restricted common stock, net
5,920,927

 
2,340,194

Proceeds from the exercise of stock options
360,225

 
6,000

Net cash provided by (used in) financing activities
6,281,152

 
(613,474
)
Net increase (decrease) in cash and cash equivalents
2,783,978

 
(5,267,817
)
Cash and cash equivalents, beginning of the period
1,186,033

 
7,713,899

Cash and cash equivalents, end of the period
$
3,970,011

 
$
2,446,082

Supplemental disclosures of cash flows information:
 

 
 

Cash paid for interest
$
91,076

 
$
294,219







NASDAQ: TGEN 3Q 2015 Earnings


 
Participants John Hatsopoulos •Co-Chief Executive Officer, Director Benjamin Locke •Co-Chief Executive Officer Robert Panora •President & Chief Operating Officer David Garrison •Chief Financial Officer Ariel Babcock •Director, Investor Relations 2 3Q 2015 Earnings Call


 
Safe Harbor Statement This presentation includes forward-looking statements within the meaning of Section 27-A of the Securities Act of 1933, and Section 21-E of the Securities Exchange Act of 1934. Such statements include declarations regarding the intent, belief, or current expectations of the Company and its management. Prospective investors are cautioned that any such forward looking statements are not guarantees of future performance, and involve a number of risks and uncertainties that can materially and adversely affect actual results as identified from time to time in the Company‘s SEC filings. Forward looking statements provided herein as of a specified date are not hereby reaffirmed or updated. 3 3Q 2015 Earnings Call


 
Tecogen Revolutionizing Distributed Generation 4 Other Build/Sell/Service Business  Gas Driven Chillers  Gas Driven Heat Pumps (Ilios)  Ultra Emission Retrofit Kits  Turnkey Installation Services Tecogen Core Business  Build, Sell, Install, and Service Advanced, Modular Combined Heat and Power (CHP) Systems  Proprietary Technology  Industry Leader Tecogen CHP System Heat, Power and Cooling that is Cheaper, Cleaner, and More Reliable 3Q 2015 Earnings Call


 
3Q 2015 Summary: metrics for growth REVENUE  Total 3Q15 Revenue of $4.68M vs. $4.18M in 3Q14, 12% Y/Y total revenue growth  YTD 2015 Revenue of $17.16M vs. $12.93M in 2014, 33% Y/Y growth  Highest ever reported 3Q revenue GROSS MARGIN  3Q15 combined Gross Margin of 35.7% vs. 26.1% in 3Q14, over 900 bps improvement Y/Y  Margins benefitting from leverage of fixed cost base, manufacturing cost cutting initiatives  Delivering combined gross margins in-line with management’s 35% guidance goal BACKLOG  Current backlog (as of 11/6/15) of $11.0M  Reiterating near term >$10M ongoing backlog goal 5 3Q 2015 Earnings Call


 
Current Backlog: $11.0 mill. 6 3Q 2015 Earnings Call Other 2% Athletic Club 5% Office/Mixed Use 6% Industrial 6% School 9% Senior Homes 9% Correctional Facility 14% Hotel 18% Multi-Unit Resi. 31%


 
Executing on Growth Strategy ILIOS UPDATE  First sales to new Atlanta market  Added sales reps in Atlanta and Chicago  Successfully commissioned the largest (7 unit) Ilios installation to-date Ultera™ EMISSIONS Rebranding of emissions technology to strengthen the system as a stand-alone product and better differentiate Tecogen’s valuable intellectual property SALES TEAM  New England sales agent added  Tecogen direct sales force added 2 new members  Remains a priority for growth DREXEL HAMILTON MICRO CAP INVESTOR FORUM John Hatsopoulos, co-CEO, presenting to investors in New York City on Thursday November 12th at 10:00 am EST. Updated investor presentation will be posted at www.investors.tecogen.com INVESTOR RELATIONS Addition of in-house investor relations department completed as discussed on the 2Q15 conference call 7 3Q 2015 Earnings Call


 
Ultera™ Emissions • BioFuel Application Success– – Retrofit kit installed on 50L Caterpillar engine – Initial results show successful emissions reduction at Southern California wastewater treatment plant – BioFuel engines must comply with stricter emissions regulations in So. Cal. beginning in 2017 – Discussions initiated with other industry representatives for similar orders – American BioGas Council estimates there are over 1800 operational biogas fueled engines nationwide • Standby Generator Retrofits – – Southern California Phase 2 order received, initial units expected to be operational in 1Q16 – Following 30 days of operation and emission results verification, air permit expected to be issued making Tecogen Ultera retrofitted engine the first engine to comply with the new emissions standards without heat recovery benefit • Other Natural Gas Applications – – Industry group proposal submitted – Formal evaluation of application of Ultera technology proposal to the natural gas small mobile engine category scheduled for 1Q16 • Emissions Advisory Group – – Examining current regulatory climate for gasoline vehicles – Held multiple meetings that included committee members and industry experts – Determination that the chemistry is similar for natural gas and gasoline – Will continue to update the investment community as the group makes progress 3Q 2015 Earnings Call 8


 
Consistent Financial Progress 9 3Q 2015 Earnings Call 0.00 5.00 10.00 15.00 20.00 25.00 2013 Q3 2014 Q1 2014 Q3 2015 Q1 2015 Q4 Goal Revenues Trailing 4 Quarters - in Millions Products Services 25.0% 27.0% 29.0% 31.0% 33.0% 35.0% 37.0% 2013 Q3 2014 Q1 2014 Q3 2015 Q1 2015 Q4 Goal Gross Margin Trailing 4 Quarters (%) 40.0% 45.0% 50.0% 55.0% 60.0% 65.0% 70.0% 2013 Q3 2014 Q1 2014 Q3 2015 Q1 2015 Q4 Goal Operating Expense as a % of Revenue Trailing 4 Quarters (%) $8.0 $9.0 $10.0 $11.0 $12.0 $13.0 Jan-15 Feb-15Mar-15 Apr-15 May-15 Jun-15 Jul-15 Aug-15 Sep-15 Oct-15 Backlog - Product and Installation $ Millions


 
Revenue Segments 10 3Q 2015 Earnings Call  Revenues • Product revenue posted strong growth from increased shipments of CHP units Y/Y • Services revenue declined as installations took longer than anticipated  Cost of Sales • Product cost benefitting from leveraging the fixed cost base • Service expense improvement despite overall service related revenue decline  Margins • Product gross margins benefiting from improved sales discipline and manufacturing cost cutting initiatives • Service gross margin improvement related to higher penetration of installations including value-add engineered services Sept. 30, 2015 Sept. 20, 2014 Y/Y Growth For the Quarter Ended: REVENUE Products 1,860,860 1,094,529 70.0% Services 2,815,182 3,081,334 -8.6% Total Revenue 4,676,042 4,175,863 12.0% COST OF SALES Products 1,262,480 1,052,199 20.0% Services 1,744,631 2,034,193 -14.2% Total Cost of Sales 3,007,111 3,086,392 -2.6% Gross Profit $1,668,931 $1,089,471 53.2% GROSS MARGIN Product Gross Margin 32.2% 3.9% 731.5% Service Gross Margin 38.0% 34.0% 11.9% Combined Gross Margin 35.7% 26.1% 36.8%


 
Financial Metrics Revenues, Margins, Growth  Three revenue streams − Product sales − Long-term service contracts provide stable ongoing revenue − Turnkey Installation through Tecogen service operations  Targeting stable book-to-bill ratio of 1 to 1.5x  Deliver ongoing expense improvement from lean manufacturing initiatives  Targeting Stable Gross Margins of 35%  Stable Backlog >$10M Tecogen Revenue Model & Outlook 11 3Q 2015 Earnings Call For the Trailing Sept. 30, 2015 Sept. 30, 2014 Y/Y Growth 4 Quarters Ended: REVENUE Products 12,322,109 7,753,307 58.9% Services 11,252,385 11,285,021 -0.3% Total Revenue 23,574,494 19,038,328 23.8% COST OF SALES Products 8,344,333 5,959,807 40.0% Services 6,660,671 7,202,492 -7.5% Total Cost of Sales 15,005,004 13,162,299 14.0% Gross Profit $8,569,490 $5,876,029 45.8% GROSS MARGIN Product Gross Margin 32.3% 23.1% Service Gross Margin 40.8% 36.2% Combined Gross Margin 36.4% 30.9%


 
Trends Going Forward 3Q 2015 Earnings Call 12 Demand for CHP Systems Remain Strong o Fundamental economics persist (high electricity prices, low cost natural gas, grid resiliency concerns) o Sales team expansion will grow markets, geographies o Ilios continues to grow Ultera Emissions Technology Advancing o Progress on retrofit projects o Advisory group developing plan for gas vehicles Continue Growing Patents and Intellectual Property Base o New patents filed o Expand to overseas patents In summary: Tecogen in Prime Position for Continued Growth


 
Q & A NASDAQ: TGEN 13 3Q 2015 Earnings Call


 
Appendix • Management Bios • Contacts 14 3Q 2015 Earnings Call


 
Management Team 15 John Hatsopoulos, Co-Chief Executive Officer & Board Member  CEO since the company‘s organization in 2000  Co-Founder of Thermo Electron Corp., which is now Fisher Scientific (NYSE:TMO)  As Thermo Electron CFO, grew company from a market capitalization of ~$100 million in 1980 to over $2.5 billion Benjamin Locke, Co-Chief Executive Officer  Co-CEO since 2014, joined the company as General Manager in June of 2013.  Prior to Tecogen, served as Director of Business Development and Governmental Affairs at Metabolix from 2001. Served as Vice President of Research at Innovative Imaging Systems prior to Metabolix. Robert Panora, Chief Operating Officer & President  COO and President since the Company‘s organization in 2000; COO of Ilios, subsidiary of Tecogen, since inception in 2009  General Manager of Tecogen’s Product Group since 1990 and Manager of Product Development, Engineering Manager, and Operations Manager of the Company since 1984 David Garrison, Chief Financial Officer, Secretary & Treasurer  Chief Financial Officer since 2014.  Over 20 years of manufacturing experience in the role of CFO. Both public and private companies from a variety of industries including medical device, defense and consumer products. 3Q 2015 Earnings Call


 
Contact Information 16 Company Information Tecogen Inc. 45 First Avenue Waltham, MA 02451 www.tecogen.com Contact John Hatsopoulos, Co-CEO 781.622.1122 John.Hatsopoulos@tecogen.com Ariel Babcock CFA, Director of Investor Relations 781.466.6413 Ariel.Babcock@tecogen.com 3Q 2015 Earnings Call


 
Tecogen (NASDAQ:TGEN)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024 Tecogen 차트를 더 보려면 여기를 클릭.
Tecogen (NASDAQ:TGEN)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024 Tecogen 차트를 더 보려면 여기를 클릭.